Stockreport

Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]

Astria Therapeutics, Inc.  (ATXS) 
PDF -- Preclinical Results for STAR-0310, Potential Best-in-Class OX40 Program for the Treatment of Atopic Dermatitis, to be Shared at Upcoming Society for Investigative De [Read more]